Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

MHRA urges nurses to report drug side effects

  • Comment

The Medicines and Healthcare products Regulatory Agency has launched a social media campaign to promote reporting of suspected side effects, as part of an European Union-wide awareness week.

It is important that the associated risks of medicines are understood and communicated to health professionals and patients, said the agency, which is running its campaign between 7-11 November.

“Our campaign will help the public, patients and healthcare professionals report potential side effects”

Mick Foy

The MHRA highlighted that it relied on the reporting of suspected side effects to ensure medicines on the market were acceptably safe, but was aware that it did not get to hear about all of them.

“Unfortunately, all reporting systems suffer from underreporting, and this is why our campaign is important to both raise awareness and help strengthen the system,” it said.

At the centre of the campaign is an animation showing the story of a patient who has a suspected adverse reaction.

It shows the drug being taken, a suspected side effect being experienced, how reports are made by patients or healthcare professionals to the medicines regulator, and how it benefits future patients.

The MHRA highlighted previous examples of the impact of side effect reporting, such as that patients taking warfarin should avoid drinking cranberry juice, and that advice not to prescribe aspirin to children had virtually eliminated Reye’s syndrome, a condition causing brain and liver swelling.

Mick Foy, group manager of the MHRA’s vigilance and risk management of medicines division said: “Our campaign will help the public, patients and healthcare professionals report potential side effects and have confidence that their reports are making a difference.”

The campaign is part of the Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) Joint Action project.

One of its main aims is to raise awareness of national reporting systems for suspected side effects in medicines, with 22 EU member states taking part in a combined social media campaign.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs